SK Biopharmaceuticals Q3 Operating Profit Rises 65.9%
SK Biopharmaceuticals reported a 65.9% year-on-year rise in third-quarter operating profit.
Related stories
Cloudbreak Pharma Announces Top-Line Results From Phase 3 CBT-001 Study
L impact | EQUITY | Nov 05, 2026, 01:01 AM UTC
D.M. Wenceslao Reports Quarterly Gross Revenue of 918.8 Million Pesos
M impact | EQUITY | Nov 05, 2026, 01:01 AM UTC
Live Oak Bancshares Prices Depositary Share Offering
M impact | EQUITY | Nov 05, 2026, 12:56 AM UTC
Nant Capital Acquires 19.99% Stake in Peraso for $10 Million
Patrick Soon-Shiong, through Nant Capital, acquired a 19.99% beneficial stake in Peraso through an investment in shares and warrants completed October 28, 2026. The stake includes
M impact | EQUITY | Nov 05, 2026, 12:56 AM UTC
News Corporation Reports Quarterly Results for Quarter Ended September 30
A machine-generated LSEG summary covers News Corporation’s results for the quarter ended September 30.
M impact | EQUITY | Nov 05, 2026, 12:56 AM UTC
News Corporation Reports Quarterly Results
News Corporation reported results for the quarter ended September 30; no figures are provided.
M impact | EQUITY | Nov 05, 2026, 12:56 AM UTC